갑상선 결절성 병변에서 Galectin-3와 HBME-1의 발현

• Published in: Annals of surgical treatment and research Vol. 71; no. 3; pp. 183 - 188
• Main Authors: 최정욱(Jung Wook Choi), 김범규(Beom Gyu Kim), 차성재(Sung Jae Cha), 이태진(Tae Jin Lee), 박성준(Sung Jun Park), 박성일(Sung Il Park)
• Format: Journal Article
• Language: Korean
• Published: 대한외과학회 01.09.2006
• Subjects: 일반외과학; 결절성 병변; Galectin-3; HBME-1; Nodular lesion; 갑상선; Thyroid
• ISSN: 2288-6575; 2288-6796

Purpose: Galectin-3 and HBME-1 have been recognized as useful markers for the diagnosis of the thyroid lesions. In this study, we investigated whether they have a diagnostic value for nodular lesions of the thyroid. Methods: We investigated the galectin-3 and HBME-1 expressions in 14 nodular hyperplasias, 30 papillary carcinomas, 17 follicular adenomas and 8 follicular carcinomas with using immunochemistry. Results: Galectin-3 was positive in 96.7% of the papillary carcinomas and this incidence was significantly higher (P=0.0001) than that of nodular hyperplasia, 7.1%. However, the galectin-3 expressions of follicular adenoma and follicular carcinoma were not significantly different. HBME-1 was positive in 50.0% of the follicular carcinomas and this incidence was significantly higher (P=0.0001) than that of follicular adenoma. Conclusion: Galectin-3 and HBME-1 may be useful markers to diagnose papillary carcinoma. Although HBME-1 contributes to differential diagnosis of follicular adenoma and follicular carcinoma, further study is required. (J Korean Surg Soc 2006;71:183-188) KCI Citation Count: 0